Professor Steve Chadban received the University Medal for Medicine at the University of Newcastle, NSW, completed physician training in Newcastle, Nephrology training and a PhD at Monash, Victoria, Australia. Following his PhD, Chadban completed post-doctoral studies in immunology at the University of Cambridge, UK. He led the Monash Transplantation Program from 1999–2002 then moved to Royal Prince Alfred Hospital, Sydney, Australia, where he works as a nephrologist and transplant physician, is Area Director of Renal Medicine for the Sydney Local Health District, Head of Unit at RPA, and Professor of Medicine and Leader of the Kidney Node, Charles Perkins Centre, University of Sydney.
Chadban is Past-President of the Transplantation Society of Australia and New Zealand and ex-Councilor of The Transplantation Society, Lead Investigator in the CARSK, BEST Fluids and AusDiab Kidney Studies. Chadban advises Government as Chair of the Transplant Advisory Group to the Organ and Tissue Authority, Co-chair of the COVID19 Rapid Response Taskforce for Donation and Transplantation, and Chair of the National Chronic Kidney Disease Expert Advisory Group (AIHW). He co-chaired the National Transplant and Donation Sector CVOID-19 Task Force. He was elected Fellow of the Australian Academy of Health and Medical Sciences in 2017. Chadban co-chaired the 2020 KDIGO Guidelines on the evaluation of candidates for Kidney transplantation, the Global standard in kidney transplant management. Chadban is Associate Editor for the American Journal of Transplantation. He has spoken at numerous national and international meetings and has produced over 400 papers published in journals including the New England Journal of Medicine, Lancet, JAMA, Annals, and the Journal of Clinical Investigation. His publications have been cited 38,853 times and his H-index is 96. Research interests include CKD and ESKD epidemiology, the molecular mechanisms of transplant rejection and kidney injury, with a focus on the kidney-gut microbiome axis, and improving outcomes for kidney transplant recipients through clinical trials. As a clinician-scientist, Chadban hopes to see lab discoveries translated into human studies and adopted into practice to improve the lives of people living with kidney disease